Clinical Trial Update: Hypothalamic Obesity Following Craniopharyngioma Surgery: A Pilot Trial of Combined Metformin and Diazoxide Therapy [Phase 2]

View source ↗

Summary

Phase 2 pilot trial evaluating combined metformin and diazoxide therapy for hypothalamic obesity after craniopharyngioma surgery; the study status is COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypothalamic Obesity

Drugs mentioned

• DIAZOXIDE (DIAZOXIDE)
• metformin (metformin)

Snippet

Sponsor: The Hospital for Sick Children | Conditions: Hypothalamic Obesity | Phase 2 | Status: COMPLETED